Jonathan Zalevsky
Hoofd Techniek/Wetenschap/O&O bij NEKTAR THERAPEUTICS
Vermogen: 340 124 $ op 30-04-2024
Actieve functies van Jonathan Zalevsky
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| NEKTAR THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 01-07-2015 | - |
ReAlta Life Sciences, Inc.
 ReAlta Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of immune system through PIC1 technology. The company was founded in 2018 and is headquartered in Norfolk, VA. | Directeur/Bestuurslid | - | - |
Invea Therapeutics, Inc.
 Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Directeur/Bestuurslid | 01-11-2021 | - |
| Independent Dir/Board Member | 01-11-2021 | - |
Loopbaan van Jonathan Zalevsky
Eerdere bekende functies van Jonathan Zalevsky
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Corporate Officer/Principal | - | - |
Opleiding van Jonathan Zalevsky
| University of Colorado Boulder | Undergraduate Degree |
| The University of California, San Francisco | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Health Technology |
ReAlta Life Sciences, Inc.
ReAlta Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services ReAlta Life Sciences, Inc. is a biotech company dedicated to harnessing the power of immune system through PIC1 technology. The company was founded in 2018 and is headquartered in Norfolk, VA. | Commercial Services |
Invea Therapeutics, Inc.
Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Beurs
- Insiders
- Jonathan Zalevsky
- Ervaring
